Nguyen Anhco's most recent trade in Atara Biotherapeutics Inc was a trade of 1,620 Common Stock done at an average price of $11.6 . Disclosure was reported to the exchange on Aug. 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Atara Biotherapeutics Inc | Anhco Nguyen | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 11.62 per share. | 18 Aug 2025 | 1,620 | 67,889 (0%) | 0% | 11.6 | 18,820 | Common Stock |
| Atara Biotherapeutics Inc | Anhco Nguyen | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 11.62 per share. | 18 Aug 2025 | 1,281 | 69,509 (0%) | 0% | 11.6 | 14,879 | Common Stock |
| Atara Biotherapeutics Inc | Anhco Nguyen | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 11.61 per share. | 18 Aug 2025 | 57 | 70,790 (0%) | 0% | 11.6 | 662 | Common Stock |
| Atara Biotherapeutics Inc | Anhco Nguyen | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 6.76 per share. | 16 May 2025 | 3,276 | 70,847 (0%) | 0% | 6.8 | 22,156 | Common Stock |
| Atara Biotherapeutics Inc | Anhco Nguyen | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 7.00 per share. | 03 Mar 2025 | 3,331 | 74,123 (0%) | 0% | 7.0 | 23,307 | Common Stock |
| Atara Biotherapeutics Inc | Anhco Nguyen | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 11.20 per share. | 18 Nov 2024 | 1,664 | 77,454 (0%) | 0% | 11.2 | 18,633 | Common Stock |
| Atara Biotherapeutics Inc | Anhco Nguyen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2024 | 45,000 | 79,118 (0%) | 0% | 0 | Common Stock | |
| Atara Biotherapeutics Inc | Anhco Nguyen | EVP, Chief Sci. & Tech Officer | Sale of securities on an exchange or to another person at price $ 6.63 per share. | 16 Aug 2024 | 1,468 | 34,471 (0%) | 0% | 6.6 | 9,731 | Common Stock |
| Atara Biotherapeutics Inc | Anhco Nguyen | EVP, Chief Sci. & Tech Officer | Sale of securities on an exchange or to another person at price $ 6.63 per share. | 16 Aug 2024 | 297 | 34,174 (0%) | 0% | 6.6 | 1,969 | Common Stock |
| Atara Biotherapeutics Inc | Anhco Nguyen | EVP, Chief Sci. & Tech Officer | Sale of securities on an exchange or to another person at price $ 6.62 per share. | 16 Aug 2024 | 56 | 34,118 (0%) | 0% | 6.6 | 371 | Common Stock |
| Atara Biotherapeutics Inc | Anhco Nguyen | EVP, Chief Sci. & Tech Officer | Sale of securities on an exchange or to another person at price $ 0.62 per share. | 16 May 2024 | 42,899 | 898,498 (1%) | 0% | 0.6 | 26,469 | Common Stock |
| Atara Biotherapeutics Inc | Anhco Nguyen | EVP, Chief Sci. & Tech Officer | Sale of securities on an exchange or to another person at price $ 0.72 per share. | 04 Mar 2024 | 10,746 | 941,397 (1%) | 0% | 0.7 | 7,737 | Common Stock |
| Atara Biotherapeutics Inc | Nguyen Anhco | EVP, Chief Sci. & Tech Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2024 | 675,000 | 952,143 (1%) | 1% | 0 | Common Stock |